We are live on
!
Find out more
ACM
ADAR1 Capital Management Portfolio holdings
AUM
$1.66B
1-Year Est. Return
340.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.25%
1 Year Est. Return
+340.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.66B
AUM Growth
+$327M
(+24%)
Cap. Flow
+$308M
Cap. Flow
% of AUM
18.5%
Top 10 Holdings %
Top 10 Hldgs %
40.47%
Holding
329
New
71
Increased
98
Reduced
59
Closed
29
Top Buys
| 1 |
Beam Therapeutics
BEAM
|
+$40.1M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
+$37.1M |
| 3 |
Denali Therapeutics
DNLI
|
+$36.2M |
| 4 |
Inspire Medical Systems
INSP
|
+$27.3M |
| 5 |
Vir Biotechnology
VIR
|
+$21.9M |
Top Sells
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$39.4M |
| 2 |
RAPT
RAPT Therapeutics
RAPT
|
+$17.3M |
| 3 |
CDTX
Cidara Therapeutics
CDTX
|
+$13.2M |
| 4 |
Fulcrum Therapeutics
FULC
|
+$10.4M |
| 5 |
Arbutus Biopharma
ABUS
|
+$9.98M |
Sector Composition
| 1 | Healthcare | 90.27% |
| 2 | Financials | 1.54% |
| 3 | Technology | 0.08% |
| 4 | Industrials | 0.08% |
| 5 | Materials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Relmada Therapeutics
RLMD
$647M
| $3.15M | 0.19% |
451,918
+421,052
| +1,364% | +$1.99M |
|
102
Perspective Therapeutics
CATX
$362M
| $3.12M | 0.19% |
749,335
+654,142
| +687% | +$2.76M |
|
103
Corbus Pharmaceuticals
CRBP
$166M
| $3.12M | 0.19% |
331,781
+45,000
| +16% | +$379K |
|
104
Eledon Pharmaceuticals
ELDN
$308M
| $3M | 0.18% |
974,421
-847,391
| -47% | -$2M |
|
105
Pharvaris
PHVS
$2.41B
| $2.98M | 0.18% |
105,528
+20,000
| +23% | +$534K |
|
|
APLS
106
DELISTED
Apellis Pharmaceuticals
APLS
| $2.92M | 0.18% |
72,500
+52,500
| +263% | +$1.13M |
|
107
Edgewise Therapeutics
EWTX
$4.34B
| $2.85M | 0.17% |
90,599
-400
| -0.4% | -$11.5K |
|
108
PepGen
PEPG
$160M
| $2.85M | 0.17% |
1,607,638
+1,570,796
| +4,264% | +$8.83M |
|
109
Capricor Therapeutics
CAPR
$1.17B
| $2.75M | 0.17% |
+90,593
| New | +$2.41M |
|
|
MASI
110
DELISTED
Masimo
MASI
| $2.67M | 0.16% |
15,000
| – | – |
|
111
Inovio Pharmaceuticals
INO
$95.4M
| $2.56M | 0.15% |
1,470,108
-14,900
| -1% | -$24.5K |
|
112
Teleflex
TFX
$6.04B
| $2.53M | 0.15% |
21,186
-59,441
| -74% | -$6.55M |
|
|
DRUG
113
Bright Minds Biosciences
DRUG
$740M
| $2.47M | 0.15% |
33,900
+30,400
| +869% | +$2.45M |
|
|
BIOA
114
BioAge Labs
BIOA
$985M
| $2.37M | 0.14% |
135,560
| – | – |
|
115
Alector
ALEC
$163M
| $2.26M | 0.14% |
1,050,000
-58,000
| -5% | -$116K |
|
116
Pfizer
PFE
$144B
| $2.17M | 0.13% |
77,400
+5,000
| +7% | +$133K |
|
117
Delcath Systems
DCTH
$456M
| $2.08M | 0.13% |
224,385
| – | – |
|
118
Biogen
BIIB
$29.6B
| $2.02M | 0.12% |
11,000
-13,300
| -55% | -$2.45M |
|
|
CNTB
119
Connect Biopharma Holdings
CNTB
$152M
| $1.95M | 0.12% |
+742,400
| New | +$1.94M |
|
120
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $1.92M | 0.12% |
+15,000
| New | +$1.87M |
|
121
Summit Therapeutics
SMMT
$11.3B
| $1.74M | 0.1% |
91,869
| – | – |
|
122
Globus Medical
GMED
$11B
| $1.73M | 0.1% |
20,100
| – | – |
|
123
Alkermes
ALKS
$8.79B
| $1.64M | 0.1% |
46,400
-17,300
| -27% | -$537K |
|
124
CALL
uniQure
QURE
$2.76B
| $1.64M | 0.1% |
100,000
+70,000
| +233% | +$1.42M |
|
|
SLNO
125
DELISTED
Soleno Therapeutics
SLNO
| $1.57M | 0.09% |
46,830
+5,000
| +12% | +$196K |
|
Similar funds
GWM
GACM
RIA
CPO
NRI
JPM
GC
FA